• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019年冠状病毒病大流行对ST段抬高型心肌梗死直接经皮冠状动脉介入治疗的影响。

The impact of the COVID-19 pandemic on the delivery of primary percutaneous coronary intervention in STEMI.

作者信息

Frain Kristina, Rathod Krishnaraj S, Tumi Ebrahiem, Chen Yang, Hamshere Stephen, Choudry Fizzah, Akhtar Mohammed M, Curtis Miles, Amersey Rajiv, Guttmann Oliver, O'Mahony Constantinos, Jain Ajay, Wragg Andrew, Baumbach Andreas, Mathur Anthony, Jones Daniel A, Rees Paul

机构信息

Faculty of Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London London E1 4NS, UK.

St Bartholomew's Hospital, Barts Health NHS Trust London EC1A 7BE, UK.

出版信息

Am J Cardiovasc Dis. 2021 Oct 25;11(5):647-658. eCollection 2021.

PMID:34849298
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8611259/
Abstract

OBJECTIVES

The clinical environment has been forced to adapt to meet the unprecedented challenges posed by the COVID-19 pandemic. Intensive care facilities were expanded in anticipation of the pandemic where the consequences include severe delays in elective procedures. Emergent procedures such as Percutaneous Coronary Intervention (PCI) in acute myocardial infarction (AMI) in which delays in timely delivery have well established adverse prognostic effects must also be explored in the context of changes in procedure and public behaviour associated with the COVID-19 pandemic. The aim for this single centre retrospective cohort study is to determine if door-to-balloon (D2B) times in PCI for ST Elevation Myocardial Infarction (STEMI) during the United Kingdom's first wave of the COVID-19 pandemic differed from pre-COVID-19 populations.

METHODS

Data was extracted from our single centre PCI database for all patients that underwent pPCI for STEMI. The reference (Pre-COVID-19) cohort was collected over the period 01-03-2019 to 31-05-2019 and the exposure group (COVID-19) over the period 01-03-2020 to 31-05-2020. Baseline patient characteristics for both populations were extracted. The primary outcome measurement was D2B times. Secondary outcome measurements included: time of symptom onset to call for help, transfer time to first hospital, transfer time from non-PCI to PCI centre, time from call-to-help to PCI centre, time to table and onset of symptoms to balloon time. Categorical and continuous variables were assessed with Chi squared and Mann-Whitney U analysis respectively. Procedural times were calculated and compared in the context of heterogeneity findings.

RESULTS

4 baseline patient characteristics were unbalanced between populations with statistical significance (P<0.05). The pre-covid-19 cohort was more likely to have suffered out of hospital cardiac arrest (OHCA) and had left circumflex disease, whereas the 1 wave cohort were more likely to have been investigated with left ventriculography and be of Afro-Caribbean origin. No statistically significant difference in in-hospital procedural times was found with D2B, C2B, O2B times comparable between groups. Pre-hospital delays were the greatest contributors in missed target times: the 1 wave group had significantly longer delayed time of symptom onset to call for help (Control: 31 mins; IQR [82.5] vs 1 wave: 60 mins; IQR [90.0], P=0.001) and time taken from call for help to arrival at the PCI hospital (control: 72 mins; IQR [23] vs 1 wave: 80 mins; IQR [66.5], P=0.042).

CONCLUSION

Enhanced infection prevention and control procedures considering the COVID-19 pandemic did not impede the delivery of pPCI in our single centre cohort. The public health impact of the pandemic has been demonstrated with times being significantly impacted by patient related delays. The recovery of public engagement in emergency medical services must become the focus for public health initiatives as we emerge from the height of COVID-19 disease burden in the UK.

摘要

目的

临床环境被迫做出调整,以应对新冠疫情带来的前所未有的挑战。为应对疫情,重症监护设施得到了扩充,其后果包括择期手术严重延迟。对于诸如急性心肌梗死(AMI)的经皮冠状动脉介入治疗(PCI)这类紧急手术,在与新冠疫情相关的手术流程和公众行为发生变化的背景下,也必须对及时实施手术的延迟所产生的不良预后影响进行探究。这项单中心回顾性队列研究的目的是确定在英国第一波新冠疫情期间,ST段抬高型心肌梗死(STEMI)患者接受PCI治疗时的门球时间(D2B)是否与新冠疫情之前的人群有所不同。

方法

从我们单中心的PCI数据库中提取所有接受直接PCI治疗STEMI患者的数据。参照组(新冠疫情之前)的数据收集时间为2019年3月1日至2019年5月31日,暴露组(新冠疫情期间)的数据收集时间为2020年3月1日至2020年5月31日。提取两组人群的基线患者特征。主要结局指标是D2B时间。次要结局指标包括:症状发作至呼救时间、转运至第一家医院的时间、从非PCI医院转运至PCI中心的时间、从呼救至到达PCI中心的时间、上台时间以及症状发作至球囊扩张时间。分别采用卡方检验和曼-惠特尼U检验对分类变量和连续变量进行评估。在存在异质性结果的情况下计算并比较手术时间。

结果

4项基线患者特征在两组人群之间存在统计学意义上的不平衡(P<0.05)。新冠疫情之前的队列更有可能发生院外心脏骤停(OHCA)且患有左旋支病变,而第一波疫情队列更有可能接受左心室造影检查且为非洲加勒比裔。在住院手术时间方面未发现统计学上的显著差异,两组之间的D2B、C2B、O2B时间相当。院前延迟是未达目标时间的最大因素:第一波疫情组症状发作至呼救的延迟时间显著更长(对照组:31分钟;四分位间距[82.5],而第一波疫情组:60分钟;四分位间距[90.0],P=0.001)以及从呼救至到达PCI医院的时间(对照组:72分钟;四分位间距[23],而第一波疫情组:80分钟;四分位间距[66.5],P=0.042)。

结论

考虑到新冠疫情而加强的感染预防和控制措施并未妨碍我们单中心队列中直接PCI的实施。疫情对公众健康的影响已得到证实,患者相关延迟对时间产生了显著影响。随着我们从英国新冠疾病负担的高峰期走出,恢复公众对紧急医疗服务的参与度必须成为公共卫生举措的重点。

相似文献

1
The impact of the COVID-19 pandemic on the delivery of primary percutaneous coronary intervention in STEMI.2019年冠状病毒病大流行对ST段抬高型心肌梗死直接经皮冠状动脉介入治疗的影响。
Am J Cardiovasc Dis. 2021 Oct 25;11(5):647-658. eCollection 2021.
2
Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study.随着时间推移,直接经皮冠状动脉介入治疗中门球时间与死亡率之间的关系:一项回顾性研究
Lancet. 2015 Mar 21;385(9973):1114-22. doi: 10.1016/S0140-6736(14)61932-2. Epub 2014 Nov 19.
3
Inter-hospital transfers and door-to-balloon times for STEMI: a single centre cohort study.ST段抬高型心肌梗死的院间转运及门球时间:一项单中心队列研究。
J Geriatr Cardiol. 2020 Jun;17(6):321-329. doi: 10.11909/j.issn.1671-5411.2020.06.001.
4
Association of the COVID-19 Pandemic on Treatment Times for ST-Elevation Myocardial Infarction: Observations from the Los Angeles County Regional System.COVID-19 大流行对 ST 段抬高型心肌梗死治疗时间的影响:来自洛杉矶县区域系统的观察。
Am J Cardiol. 2024 Feb 15;213:93-98. doi: 10.1016/j.amjcard.2023.11.035. Epub 2023 Nov 26.
5
Impact of COVID-19 pandemic early response measures on myocardial infarctions and acute cardiac care in Singapore.COVID-19 大流行早期应对措施对新加坡心肌梗死和急性心脏护理的影响。
Int J Qual Health Care. 2023 Jun 1;35(2). doi: 10.1093/intqhc/mzad023.
6
Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: A nationwide study.COVID-19大流行期间急性心肌梗死的治疗延误及院内结局:一项全国性研究。
Anatol J Cardiol. 2020 Nov;24(5):334-342. doi: 10.14744/AnatolJCardiol.2020.98607.
7
Outcome of inter-hospital transfer versus direct admission for primary percutaneous coronary intervention: An observational study of 25,315 patients with ST-elevation myocardial infarction from the London Heart Attack Group.院内转院与直接入院行直接经皮冠状动脉介入治疗对 ST 段抬高型心肌梗死患者的结局影响:来自伦敦心肌梗死研究组的 25315 例患者的观察性研究。
Eur Heart J Acute Cardiovasc Care. 2020 Dec;9(8):948-957. doi: 10.1177/2048872619882340. Epub 2020 Mar 20.
8
Achieving sustainable first door-to-balloon times of 90 minutes for regional transfer ST-segment elevation myocardial infarction.实现区域转诊 ST 段抬高型心肌梗死患者首次门球时间 90 分钟的可持续性。
JACC Cardiovasc Interv. 2013 Oct;6(10):1064-71. doi: 10.1016/j.jcin.2013.05.018. Epub 2013 Sep 18.
9
The effect of door-to-balloon delay in primary percutaneous coronary intervention on clinical outcomes of STEMI: a systematic review and meta-analysis protocol.直接经皮冠状动脉介入治疗中门球囊扩张延迟对ST段抬高型心肌梗死临床结局的影响:一项系统评价和Meta分析方案
Syst Rev. 2016 Aug 2;5(1):130. doi: 10.1186/s13643-016-0304-7.
10
Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction.COVID-19 对 ST 段抬高型心肌梗死经皮冠状动脉介入治疗的影响。
Heart. 2020 Dec;106(23):1805-1811. doi: 10.1136/heartjnl-2020-317650. Epub 2020 Aug 31.

本文引用的文献

1
Impact of COVID-19 on primary percutaneous coronary intervention centres in the UK: a survey.2019冠状病毒病对英国主要经皮冠状动脉介入治疗中心的影响:一项调查
Br J Cardiol. 2020 Jun 11;27(2):17. doi: 10.5837/bjc.2020.017. eCollection 2020.
2
COVID-19 and changes in activity and treatment of ST elevation MI from a UK cardiac centre.英国一家心脏中心的新冠疫情与ST段抬高型心肌梗死的活动及治疗变化
Int J Cardiol Heart Vasc. 2021 Apr;33:100736. doi: 10.1016/j.ijcha.2021.100736. Epub 2021 Feb 23.
3
Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction.COVID-19 对 ST 段抬高型心肌梗死经皮冠状动脉介入治疗的影响。
Heart. 2020 Dec;106(23):1805-1811. doi: 10.1136/heartjnl-2020-317650. Epub 2020 Aug 31.
4
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.COVID-19 大流行期间的 ST 段抬高型心肌梗死:区域性公共服务医疗中心的观察结果。
Circ Cardiovasc Interv. 2020 Aug;13(8):e009413. doi: 10.1161/CIRCINTERVENTIONS.120.009413. Epub 2020 Aug 14.
5
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.COVID-19 大流行与英格兰急性冠状动脉综合征的入院率及治疗管理。
Lancet. 2020 Aug 8;396(10248):381-389. doi: 10.1016/S0140-6736(20)31356-8. Epub 2020 Jul 14.
6
Effect of the COVID-19 Pandemic on Treatment Delays in Patients with ST-Segment Elevation Myocardial Infarction.新冠疫情对ST段抬高型心肌梗死患者治疗延迟的影响
J Clin Med. 2020 Jul 10;9(7):2183. doi: 10.3390/jcm9072183.
7
Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes.2019年冠状病毒病大流行对ST段抬高型心肌梗死表现及院内结局的影响
Circ Cardiovasc Interv. 2020 Jul;13(7):e009438. doi: 10.1161/CIRCINTERVENTIONS.120.009438.
8
Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center.COVID-19 大流行对 ST 段抬高型心肌梗死患者的影响:来自英国心脏中心的见解。
Am Heart J. 2020 Aug;226:45-48. doi: 10.1016/j.ahj.2020.04.022. Epub 2020 May 11.
9
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
Eur J Cardiothorac Surg. 2019 Jan 1;55(1):4-90. doi: 10.1093/ejcts/ezy289.
10
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.